D
Axsome Therapeutics, Inc. AXSM
$118.70 $1.561.33% NASDAQ
Recommendation
Prev Close
$111.29
Volume
608,862
Avg Vol (90D)
647,297
Market Cap
$5.55B
Dividend & Yield
--
52-Week Range
$75.56 - $139.13
P/E (TTM)
--
EPS (TTM)
-$5.08
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Analysts Are Bullish on Top Healthcare Stocks: Axsome Therapeutics (AXSM), Rocket Pharmaceuticals (RCKT)
8/21/2025 - TipRanks Financial Blog
Axsome Therapeutics (AXSM, $116.99) price may drop as it broke higher Bollinger Band on Aug 20, 2025
8/21/2025 - Tickeron - Stocks
Axsome Therapeutics (AXSM, $116.99) RSI Indicator left the overbought zone on August 20, 2025
8/21/2025 - Tickeron - Stocks
Axsome Therapeutics Receives Paragraph IV Certification Notice
8/20/2025 - TipRanks Financial Blog
RBC Capital Keeps Their Buy Rating on Axsome Therapeutics (AXSM)
8/20/2025 - TipRanks Financial Blog
Versor Investments LP Invests $2.29 Million in Axsome Therapeutics, Inc. (NASDAQ:AXSM)
8/19/2025 - MarketBeat
The Implied Analyst 12-Month Target For AVIE
8/19/2025 - ETF Channel
Invesco Ltd. Boosts Stake in Axsome Therapeutics, Inc. (NASDAQ:AXSM)
8/18/2025 - MarketBeat
Fox Run Management L.L.C. Boosts Stake in Axsome Therapeutics, Inc. (NASDAQ:AXSM)
8/16/2025 - MarketBeat
Deutsche Bank AG Sells 25,567 Shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM)
8/16/2025 - MarketBeat
Axsome Therapeutics (AXSM, $109.39) price moved above its 50-day Moving Average on August 13, 2025
8/14/2025 - Tickeron - Technical Analysis
Axsome Therapeutics (AXSM, $109.39) price may drop as it broke higher Bollinger Band on Aug 13, 2025
8/14/2025 - Tickeron - Technical Analysis
Virtu Financial LLC Acquires New Holdings in Axsome Therapeutics, Inc. (NASDAQ:AXSM)
8/13/2025 - MarketBeat
Earnings Momentum and Capital Raise Could Be a Game Changer for Axsome Therapeutics (AXSM)
8/13/2025 - Simply Wall St
Axsome Therapeutics management to meet with Needham
8/12/2025 - The Fly
Axsome Therapeutics management to meet with Needham
8/11/2025 - The Fly
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Shares Bought by Connor Clark & Lunn Investment Management Ltd.
8/11/2025 - MarketBeat
XTX Topco Ltd Sells 9,794 Shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM)
8/10/2025 - MarketBeat
FY2026 EPS Estimates for AXSM Increased by Cantor Fitzgerald
8/9/2025 - MarketBeat
HC Wainwright Issues Pessimistic Estimate for AXSM Earnings
8/9/2025 - MarketBeat
The Bull Case For Axsome Therapeutics (AXSM) Could Change Following Strong Q2 Revenue and Narrowing Losses
8/8/2025 - Simply Wall St
FY2026 EPS Estimates for AXSM Decreased by Cantor Fitzgerald
8/8/2025 - MarketBeat
HC Wainwright Brokers Lower Earnings Estimates for AXSM
8/8/2025 - MarketBeat
Leerink Partnrs Issues Optimistic Estimate for AXSM Earnings
8/8/2025 - MarketBeat
Mizuho Securities Sticks to Its Buy Rating for Axsome Therapeutics (AXSM)
8/7/2025 - TipRanks Financial Blog
Income Statement
Total Revenue (TTM)
$495.03M
EBITDA (TTM)
-$199.64M
EBIT (TTM)
-$208.15M
Net Income (TTM)
-$246.90M
Balance Sheet
Total Assets (Q)
$639.79M
Total Debt (Q)
$217.31M
Total Liabilities (Q)
$566.71M
Book Value Per Share (Q)
$1.47
Cash Flow
Cash from Operations (TTM)
-$120.63M
Cash from Investing (TTM)
-$471.00K
Cash from Financing (TTM)
$108.46M
Net Change in Cash (TTM)
-$12.64M
Filings
Filing Date
Monday, August 4, 2025
Period Date
Monday, June 30, 2025
Next Filing
Week of Nov 10 and 14 (est)
Price History
Loading...
Beta
1.00
7-Day Total Return
12.81%
30-Day Total Return
7.21%
60-Day Total Return
14.17%
90-Day Total Return
21.06%
Year to Date Total Return
35.95%
1-Year Total Return
35.04%
2-Year Total Return
66.80%
3-Year Total Return
84.16%
5-Year Total Return
53.04%
52-week Low
Dec 30, 2024 - $75.56
52-week High
Feb 21, 2025 - $139.13
Valuation
Market Cap
$5.55B - Mid Cap
Enterprise Value
$5.47B
Price/Sales (TTM)
11.12
Price/Book (Q)
75.87
Dividends and Shares
Shares Outstanding
49.44
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.axsome.com
Phone Number
212 332 3241
Address
One World Trade Center
New York, NY 10007
Country
United States
Year Founded
2012
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Axsome Therapeutics, Inc., a biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States. The company’s... more
NASDAQ 08/22/2025 3:55PM Eastern Quotes delayed